[R35] New and Disruptive Therapeutic Approaches to Target Fundamental Molecular Mechanisms Underlying Atrial Fibrillation
Ente: National Heart Lung and Blood Institute
Scadenza: 2028-12-31
Importo max: $964,320
Paese: US
Descrizione
PROJECT SUMMARY
Atrial fibrillation (AF) is the most common heart rhythm disorder that affects >3 million Americans and is a
major cause of stroke. Since AF is primarily an age-related disease, it is fast becoming an epidemic in a rapidly
aging population. Unfortunately, current therapeutic approach
Settori: National Heart Lung and Blood Institute
Registrati gratis su Bandolo per trovare bandi compatibili con la tua azienda.